SPRINGFIELD, Ill. – Cancer patients would have greater access to innovative treatment technology under legislation sponsored by state Rep. Theresa Mah, D-Chicago, supporting the accreditation of an additional National Cancer Institute (NCI)-designated cancer center in Illinois.
“Cancer is a devastating diagnosis regardless of who receives it,” said Mah. “No matter where they live or their level of income, every cancer patient deserves the highest quality care for the best chance at beating their disease. Having a third NCI-designated cancer center in Illinois means new research and treatment options to offer patients hope.”
Illinois currently has two NCI-accredited cancer centers, both of which are located in Chicago. Mah is sponsoring House Joint Resolution 4, which supports the accreditation of a third NCI-designated cancer center in Illinois. This designation is given to medical facilities that are at the forefront of cancer research, treatment and clinical trials, which become eligible for exclusive federal funding opportunities with accreditation. In addition to bringing in millions of dollars in additional federal funding for cancer research, an additional NCI-designated cancer center would attract leading doctors to Illinois to help train the next generation of health care workers.
“With this legislation, Illinois has an opportunity to become a national leader in improving cancer care outcomes, and addressing health disparities,” said Mah. “This will have a major impact on the future of cancer treatment in Illinois, ultimately saving lives.”
Mah is serving her second term representing the 2nd District, which includes the Chicago neighborhoods of McKinley Park, Pilsen, Chinatown, Bridgeport, Brighton Park and Back of the Yards. For more information, please contact Mah’s district office at 872-281-5775.